DE69824718D1 - Pharmazeutische zusammensetzung zur förderung von osteoblasten, die eine carnitin-verbindung und dhea oder dhea-s enthält - Google Patents

Pharmazeutische zusammensetzung zur förderung von osteoblasten, die eine carnitin-verbindung und dhea oder dhea-s enthält

Info

Publication number
DE69824718D1
DE69824718D1 DE69824718T DE69824718T DE69824718D1 DE 69824718 D1 DE69824718 D1 DE 69824718D1 DE 69824718 T DE69824718 T DE 69824718T DE 69824718 T DE69824718 T DE 69824718T DE 69824718 D1 DE69824718 D1 DE 69824718D1
Authority
DE
Germany
Prior art keywords
dhea
east
pharmaceutical composition
carnitin
promoting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69824718T
Other languages
English (en)
Other versions
DE69824718T2 (de
Inventor
Claudio Cavazza
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Application granted granted Critical
Publication of DE69824718D1 publication Critical patent/DE69824718D1/de
Publication of DE69824718T2 publication Critical patent/DE69824718T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69824718T 1997-04-16 1998-04-03 Pharmazeutische zusammensetzung zur förderung von osteoblasten, die eine carnitin-verbindung und dhea oder dhea-s enthält Expired - Lifetime DE69824718T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT97RM000217A IT1291141B1 (it) 1997-04-16 1997-04-16 Composizione farmaceutica comprendente una alcanoil l-carnitina, atta a stimolare la moltiplicazione e la crescita degli osteoblasti
ITRM970217 1997-04-16
PCT/IT1998/000076 WO1998046233A1 (en) 1997-04-16 1998-04-03 Osteoblast-promoting pharmaceutical composition comprising a carnitine compound and dhea or dhea-s

Publications (2)

Publication Number Publication Date
DE69824718D1 true DE69824718D1 (de) 2004-07-29
DE69824718T2 DE69824718T2 (de) 2005-06-30

Family

ID=11404977

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69824718T Expired - Lifetime DE69824718T2 (de) 1997-04-16 1998-04-03 Pharmazeutische zusammensetzung zur förderung von osteoblasten, die eine carnitin-verbindung und dhea oder dhea-s enthält

Country Status (17)

Country Link
US (1) US6329358B1 (de)
EP (1) EP0977576B1 (de)
JP (1) JP2001520644A (de)
KR (1) KR20010006465A (de)
AT (1) ATE269707T1 (de)
AU (1) AU730710B2 (de)
BR (1) BR9809762A (de)
CA (1) CA2286719C (de)
DE (1) DE69824718T2 (de)
DK (1) DK0977576T3 (de)
ES (1) ES2224380T3 (de)
HK (1) HK1025243A1 (de)
IT (1) IT1291141B1 (de)
NZ (1) NZ500533A (de)
PT (1) PT977576E (de)
SI (1) SI0977576T1 (de)
WO (1) WO1998046233A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1317079B1 (it) 2000-12-21 2003-05-26 Sigma Tau Ind Farmaceuti Uso della isovaleril l-carnitina per la preparazione di un medicamentoper la prevenzione e cura dell'osteoporosi.
US6911438B2 (en) * 2001-09-12 2005-06-28 Jonathan V. Wright Hormone replacement formulation
US20080069814A1 (en) * 2005-01-05 2008-03-20 Novacea, Inc. Prevention of Thrombotic Disorders with Active Vitamin D Compounds or Mimics Thereof
AU2006239883A1 (en) * 2005-04-22 2006-11-02 Novacea, Inc. Treatment, prevention and amelioration of pulmonary disorders associated with chemotherapy or radiotherapy with active vitamin D compounds or mimics thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1245869B (it) * 1991-06-05 1994-10-25 Sigma Tau Ind Farmaceuti Impiego di propionil l-carnitina per il recupero del tono muscolare in soggetti immobilizzati
US5240961A (en) * 1992-07-02 1993-08-31 Shug Austin L Method of treating reduced insulin-like growth factor and bone loss associated with aging
US5326569A (en) * 1992-12-23 1994-07-05 Abbott Laboratories Medical foods for the nutritional support of child/adult metabolic diseases
AU5855794A (en) * 1993-01-19 1994-08-15 Endorecherche Inc. Therapeutic uses and delivery systems of dehydroepiandrosterone
WO1995005168A1 (en) * 1993-08-19 1995-02-23 Shug Austin L Delayed release carnitine
US5569457A (en) * 1994-11-18 1996-10-29 Shug; Austin L. Method of stimulating antibody formation
US5945412A (en) * 1996-12-09 1999-08-31 Merck & Co., Inc. Methods and compositions for preventing and treating bone loss

Also Published As

Publication number Publication date
WO1998046233A1 (en) 1998-10-22
SI0977576T1 (en) 2004-10-31
ATE269707T1 (de) 2004-07-15
EP0977576A1 (de) 2000-02-09
KR20010006465A (ko) 2001-01-26
ES2224380T3 (es) 2005-03-01
ITRM970217A1 (it) 1998-10-16
JP2001520644A (ja) 2001-10-30
US6329358B1 (en) 2001-12-11
HK1025243A1 (en) 2000-11-10
PT977576E (pt) 2004-11-30
EP0977576B1 (de) 2004-06-23
DE69824718T2 (de) 2005-06-30
CA2286719A1 (en) 1998-10-22
AU7077498A (en) 1998-11-11
NZ500533A (en) 2001-03-30
AU730710B2 (en) 2001-03-15
DK0977576T3 (da) 2004-11-01
CA2286719C (en) 2008-06-10
IT1291141B1 (it) 1998-12-29
BR9809762A (pt) 2000-06-20

Similar Documents

Publication Publication Date Title
ATE241337T1 (de) Hautpflegemittel für gealterte haut
ES2155874T3 (es) Composiciones cosmeticas que contienen acido betulinico.
BR9602933A (pt) Compostos processos para preparação de composto e de composição farmacêutica e composto
ATE180773T1 (de) N-sulfonyl-2-oxoindol-derivate mit einer affinität für die vasopressin und/oder ocytocin rezeptoren
BR9909110A (pt) Usos de esmilagenina e anzurogenina d, compoisção farmacêutica tendo propriedades intensificadoras da função cognitiva, processo para intensificar a função cognitiva, e, composição para uso do mesmo
ES2055745T3 (es) Compuestos antigestagenicos y antiestrogenos para el tratamiento de tumores hormono-dependientes.
ATE251853T1 (de) Flüssige, orale zusammensetzung, welche eine kalziumverbindung und eine säure enthält
BR9707958A (pt) Composto, composição farmacêutica, e, processo para tratar hiperalgesia em um paciente.
ES2186952T3 (es) Esmalte para uñas de efecto antipsoriasico.
CA2343130A1 (en) Cosmetic composition
DE69503179D1 (de) Kosmetische und/oder dermatologische Zusammensetzung, die ein Tri (alpha-hydroxyacylat) von glycerin als einzigen Glycerinprecursor enthält
DE69824718D1 (de) Pharmazeutische zusammensetzung zur förderung von osteoblasten, die eine carnitin-verbindung und dhea oder dhea-s enthält
BR9915955A (pt) Composição cosmética para cuidado com a pele, processo cosmético para tratar uma pele envelhecida e uso de 4- cromanona
HUP0100066A2 (hu) Egy diol és egy alfa-hidroxisav keverékének alkalmazása hiperkeratózisos bőrbetegségek kezelésére
BR9713159A (pt) Composição substancialmente sólida, composto, composição de sal substancialmente sólida, mistura, e, processo para preparar um composto
HUP9800512A3 (en) Salts of bismuthum and antibiotica of the moenomycin group, process for producing them, their use and pharmaceutical compositions containing them
ES2120667T3 (es) Sal de l-carnitina y composiciones cosmeticas y farmaceuticas que la contienen para tratamiento de dermatosis.
DE60042192D1 (de) Verwendung von DHEA oder dessen Vorläufern und Metaboliten als Hautdepigmentierungsmittel
MX9307203A (es) COMPUESTOS ESTEROIDALES DE ACIL-3-CARBOXI-3,5-DIENO-17Ó Y 17ß -SUBSTITUIDOS.
ATE107656T1 (de) Verfahren zur herstellung von 14-alpha-hydroxy-4- androsten-3,6,17, trion.
ES2059403T3 (es) Composicion util en el tratamiento de deficiencias de estrogenos.
ID27898A (id) Metode untuk mencegah dan mengurangi bau badan
BR0211778A (pt) Método para reduzir o crescimento capilar humano, composição para a aplicação tópica à pele, uso de uréia, e, método para produzir uma composição para inibir o crescimento capilar de mamìfero
BR9807265A (pt) Processo de epoxidação seletiva para preparação de compostos farmacêuticos
DE69434600D1 (de) Pharmazeutische Zusammensetzungen, die Paracetamol und L-Cystein oder eine Vorstufe davon enthalten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition